WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Stock Ownership - Who owns Ionis Pharmaceuticals?

Insider buying vs selling

Have Ionis Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Joseph H. WenderDirector2024-05-0916,000$35.53
$568.48kBuy
Joseph Klein IiiDirector2024-05-03930$42.90
$39.89kSell
Joseph Klein IiiDirector2024-05-031,070$42.55
$45.53kSell
Joseph Klein IiiDirector2024-05-031,318$42.57
$56.11kSell
Joseph Klein IiiDirector2024-05-03682$42.95
$29.29kSell
Joseph Klein IiiDirector2024-05-031,269$42.59
$54.04kSell
Joseph Klein IiiDirector2024-05-03731$42.98
$31.42kSell
Joseph BaroldiEVP Chief Business Officer2024-04-164,006$41.60
$166.64kSell
Brian BirchlerEVP Corp and Development Ops2024-04-16905$41.66
$37.70kSell
Richard S. GearyOfficer Level 142024-02-29604$34.43
$20.79kBuy

1 of 10

IONS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IONS insiders and whales buy or sell their stock.

IONS Shareholders

What type of owners hold Ionis Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.98%21,862,735$822.48MInstitution
Vanguard Group Inc9.20%13,430,456$505.25MInstitution
T Rowe Price Investment Management Inc9.12%13,317,112$500.99MInstitution
Blackrock Inc6.69%9,771,891$367.62MInstitution
Bellevue Group Ag5.69%8,299,514$312.23MInstitution
Wellington Management Group LLP3.90%5,695,699$214.27MInstitution
Clearbridge Investments LLC3.06%4,466,191$168.02MInstitution
State Street Corp2.85%4,155,664$156.34MInstitution
Pictet Asset Management Holding Sa2.56%3,739,757$140.69MInstitution
Price T Rowe Associates Inc2.41%3,522,203$132.51MInstitution

1 of 3

IONS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IONS96.26%3.74%Net SellingNet Buying
IBRX9.56%7.74%Net Buying
BBIO56.56%43.44%Net SellingNet Selling
HALO77.92%22.08%Net SellingNet Selling
APLS74.59%25.41%Net BuyingNet Selling

Ionis Pharmaceuticals Stock Ownership FAQ

Who owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals (NASDAQ: IONS) is owned by 96.37% institutional shareholders, 3.75% Ionis Pharmaceuticals insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual Ionis Pharmaceuticals shareholder, owning 2.50M shares representing 1.71% of the company. Lilly Co Eli's Ionis Pharmaceuticals shares are currently valued at $93.28M.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.